Kern Capital
Larkspur, Californiakerncapitalllc.com
Overview
Kern Capital manages a diversified portfolio stretching from new ventures to established and profitable businesses across many industry sectors, but with a particular focus on the life sciences . The firm tends to make investments of $5 to $15 million in only a few companies each year and partners with outstanding management teams for the long term .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Latigo Biotherapeutics | Mar 2025 | Series B | Co-investor |
| GPN Vaccines | Jun 2024 | Series B Extension | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
See something wrong or outdated?